RESUMO
Objective: To determine the trends of physicians and neurologists in prescribing anti-platelet agents for secondary prevention of non-cardio embolic stroke after 3 months of stroke
Study Design: A descriptive study
Place and Duration of Study: Combined Military Hospital [CMH] Lahore over a period of four months
Material and Methods: Patients suffering from old [>/=3 months] non-cardio embolic stroke, taking anti-platelet agents for secondary prevention and visiting CMH Lahore neurology clinic. Information about their stroke and treatment was obtained from their previous investigations and medical prescriptions
Results: A total of 60 patients met the inclusion criteria of the study; 36 [60 percent] were taking a combination of clopidogrel 75mg plus Aspirin 75 mg and 12 [20 percent] received Aspirin 75 mg daily while 12 [20 percent] were getting other regimens
Conclusion: Combination of clopidogrel 75mg plus Aspirin 75 mg was the most common anti-platelet regimen prescribed for secondary prevention of non-cardio embolic stroke in our study population